We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPB icon
1526
Spectrum Brands
SPB
$2.07B
$3.62M ﹤0.01%
46,223
-802
-2% -$63.3K
LGTY
1527
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$3.62M ﹤0.01%
315,958
+184,657
+141% +$2.05M
SCHL icon
1528
Scholastic
SCHL
$792M
$3.62M ﹤0.01%
94,917
-26,348
-22% -$1.09M
FRPT icon
1529
Freshpet
FRPT
$3.22B
$3.61M ﹤0.01%
54,815
-552
-1% -$39.6K
PRDO icon
1530
Perdoceo Education
PRDO
$2.12B
$3.6M ﹤0.01%
210,644
-5,250
-2% -$80K
ECPG icon
1531
Encore Capital Group
ECPG
$2.13B
$3.6M ﹤0.01%
75,412
+469
+0.6% +$23K
TNDM icon
1532
Tandem Diabetes Care
TNDM
$1.56B
$3.6M ﹤0.01%
173,256
-2,130
-1% -$58.5K
AKRO
1533
DELISTED
Akero Therapeutics
AKRO
$3.58M ﹤0.01%
70,784
+9,610
+16% +$447K
NVEE
1534
DELISTED
NV5 Global
NVEE
$3.56M ﹤0.01%
148,040
+1,520
+1% +$39.2K
AXSM icon
1535
Axsome Therapeutics
AXSM
$10.9B
$3.55M ﹤0.01%
50,845
+4,135
+9% +$309K
TDOC icon
1536
Teladoc Health
TDOC
$1.3B
$3.55M ﹤0.01%
190,965
-2,318
-1% -$54.1K
ADEA icon
1537
Adeia
ADEA
$3.11B
$3.55M ﹤0.01%
332,193
-5,235
-2% -$55.6K
UEC icon
1538
Uranium Energy
UEC
$5.57B
$3.54M ﹤0.01%
688,022
-47,439
-6% -$193K
PHIN icon
1539
Phinia Inc
PHIN
$2.74B
$3.54M ﹤0.01%
+132,123
New +$3.66M
PLMR icon
1540
Palomar
PLMR
$3.45B
$3.53M ﹤0.01%
69,575
-565
-0.8% -$30.9K
VSXY
1541
Victoria's Secret
VSXY
$7.83B
$3.53M ﹤0.01%
211,543
-7,818
-4% -$148K
SSTK icon
1542
Shutterstock
SSTK
$219M
$3.52M ﹤0.01%
92,527
+4,326
+5% +$194K
SDRL icon
1543
Seadrill
SDRL
$2.7B
$3.51M ﹤0.01%
78,435
+4,820
+7% +$224K
FBRT
1544
Franklin BSP Realty Trust
FBRT
$657M
$3.51M ﹤0.01%
265,101
-3,597
-1% -$50.1K
CIR
1545
DELISTED
CIRCOR International, Inc
CIR
$3.51M ﹤0.01%
62,956
+1,095
+2% +$61.1K
PRMW
1546
DELISTED
Primo Water Corporation
PRMW
$3.51M ﹤0.01%
254,131
+94
+0% +$1.34K
FBNC icon
1547
First Bancorp
FBNC
$2.68B
$3.5M ﹤0.01%
124,476
-15,624
-11% -$479K
CNA icon
1548
CNA Financial
CNA
$14.1B
$3.5M ﹤0.01%
88,891
-77,503
-47% -$3.06M
DNLI icon
1549
Denali Therapeutics
DNLI
$3.97B
$3.49M ﹤0.01%
169,124
+7,142
+4% +$181K
GIII icon
1550
G-III Apparel Group
GIII
$1.5B
$3.49M ﹤0.01%
139,882
+933
+0.7% +$19.9K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.